本页面由Tiger Trade Technology Pte. Ltd.提供服务

Xenon制药

54.73
-0.0600-0.11%
盘后54.730.00000.00%17:40 EDT
成交量:137.53万
成交额:7,530.46万
市值:52.89亿
市盈率:-11.63
高:55.39
开:54.76
低:54.37
收:54.79
52周最高:63.95
52周最低:28.19
股本:9,664.28万
流通股本:8,988.95万
量比:0.80
换手率:1.53%
股息:- -
股息率:- -
每股收益(TTM):-4.7061
每股收益(LYR):-4.3646
净资产收益率:-37.53%
总资产收益率:-24.22%
市净率:3.95
市盈率(LYR):-12.54

数据加载中...

2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/13

重要事件披露

Form 8-K - Current report
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

重要事件披露

Form 8-K - Current report
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/11

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]